307 related articles for article (PubMed ID: 11220405)
1. Caffeine citrate: a review of its use in apnoea of prematurity.
Comer AM; Perry CM; Figgitt DP
Paediatr Drugs; 2001; 3(1):61-79. PubMed ID: 11220405
[TBL] [Abstract][Full Text] [Related]
2. Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.
Schoen K; Yu T; Stockmann C; Spigarelli MG; Sherwin CM
Paediatr Drugs; 2014 Apr; 16(2):169-77. PubMed ID: 24399614
[TBL] [Abstract][Full Text] [Related]
3. Caffeine citrate therapy for apnea of prematurity.
Johnson PJ
Neonatal Netw; 2011; 30(6):408-12. PubMed ID: 22052121
[No Abstract] [Full Text] [Related]
4. Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebo-controlled study.
Erenberg A; Leff RD; Haack DG; Mosdell KW; Hicks GM; Wynne BA
Pharmacotherapy; 2000 Jun; 20(6):644-52. PubMed ID: 10853619
[TBL] [Abstract][Full Text] [Related]
5. Methylxanthine treatment for apnoea in preterm infants.
Henderson-Smart DJ; De Paoli AG
Cochrane Database Syst Rev; 2010 Dec; (12):CD000140. PubMed ID: 21154343
[TBL] [Abstract][Full Text] [Related]
6. Academic Performance, Motor Function, and Behavior 11 Years After Neonatal Caffeine Citrate Therapy for Apnea of Prematurity: An 11-Year Follow-up of the CAP Randomized Clinical Trial.
Schmidt B; Roberts RS; Anderson PJ; Asztalos EV; Costantini L; Davis PG; Dewey D; D'Ilario J; Doyle LW; Grunau RE; Moddemann D; Nelson H; Ohlsson A; Solimano A; Tin W;
JAMA Pediatr; 2017 Jun; 171(6):564-572. PubMed ID: 28437520
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic methylxanthine for prevention of apnoea in preterm infants.
Henderson-Smart DJ; De Paoli AG
Cochrane Database Syst Rev; 2010 Dec; 2010(12):CD000432. PubMed ID: 21154344
[TBL] [Abstract][Full Text] [Related]
8. Caffeine citrate: when and for how long. A literature review.
Picone S; Bedetta M; Paolillo P
J Matern Fetal Neonatal Med; 2012 Oct; 25 Suppl 3():11-4. PubMed ID: 23016611
[TBL] [Abstract][Full Text] [Related]
9. Aminophylline versus caffeine citrate for apnea and bradycardia prophylaxis in premature neonates.
Larsen PB; Brendstrup L; Skov L; Flachs H
Acta Paediatr; 1995 Apr; 84(4):360-4. PubMed ID: 7795341
[TBL] [Abstract][Full Text] [Related]
10. Caffeine citrate treatment for extremely premature infants with apnea: population pharmacokinetics, absolute bioavailability, and implications for therapeutic drug monitoring.
Charles BG; Townsend SR; Steer PA; Flenady VJ; Gray PH; Shearman A
Ther Drug Monit; 2008 Dec; 30(6):709-16. PubMed ID: 19057373
[TBL] [Abstract][Full Text] [Related]
11. Periextubation caffeine in preterm neonates: a randomized dose response trial.
Steer PA; Flenady VJ; Shearman A; Lee TC; Tudehope DI; Charles BG
J Paediatr Child Health; 2003; 39(7):511-5. PubMed ID: 12969204
[TBL] [Abstract][Full Text] [Related]
12. Current options in the management of apnea of prematurity.
Bhatia J
Clin Pediatr (Phila); 2000 Jun; 39(6):327-36. PubMed ID: 10879934
[TBL] [Abstract][Full Text] [Related]
13. Caffeine in apnoeic Asian neonates: a sparse data analysis.
Lee HS; Khoo YM; Chirino-Barcelo Y; Tan KL; Ong D
Br J Clin Pharmacol; 2002 Jul; 54(1):31-7. PubMed ID: 12100222
[TBL] [Abstract][Full Text] [Related]
14. Caffeine versus theophylline for apnea of prematurity: a randomised controlled trial.
Skouroliakou M; Bacopoulou F; Markantonis SL
J Paediatr Child Health; 2009 Oct; 45(10):587-92. PubMed ID: 19751376
[TBL] [Abstract][Full Text] [Related]
15. When to start and stop caffeine and why respiratory status matters.
Davis PG
Semin Fetal Neonatal Med; 2020 Dec; 25(6):101175. PubMed ID: 33144042
[TBL] [Abstract][Full Text] [Related]
16. Caffeine versus theophylline for apnea in preterm infants.
Henderson-Smart DJ; Steer PA
Cochrane Database Syst Rev; 2010 Jan; (1):CD000273. PubMed ID: 20091506
[TBL] [Abstract][Full Text] [Related]
17. The effect of caffeine citrate on neural breathing pattern in preterm infants.
Parikka V; Beck J; Zhai Q; Leppäsalo J; Lehtonen L; Soukka H
Early Hum Dev; 2015 Oct; 91(10):565-8. PubMed ID: 26217936
[TBL] [Abstract][Full Text] [Related]
18. Long-term effects of caffeine therapy for apnea of prematurity.
Schmidt B; Roberts RS; Davis P; Doyle LW; Barrington KJ; Ohlsson A; Solimano A; Tin W;
N Engl J Med; 2007 Nov; 357(19):1893-902. PubMed ID: 17989382
[TBL] [Abstract][Full Text] [Related]
19. Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates.
Koch G; Datta AN; Jost K; Schulzke SM; van den Anker J; Pfister M
J Pediatr; 2017 Dec; 191():50-56.e1. PubMed ID: 29173321
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetic study of caffeine citrate in Chinese premature infants with apnea.
Guo A; Zhu Z; Xue J; Di X; Fan J; Huang L; Zhao P; Hu X; Xie H
J Clin Pharm Ther; 2020 Dec; 45(6):1414-1421. PubMed ID: 32737938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
